文献速递炎症性肠病

监测炎症性肠病活动度:何时、如何及为何监测

Monitoring Inflammatory Bowel Disease Activity: When, How, and Why.
PubMed 文献 · Am J Gastroenterol · 2025-06-09

炎症性肠病(IBD)包括溃疡性结肠炎和克罗恩病,症状与肠道炎症活动度常不一致。本综述讨论评估疾病活动度的不同策略及各治疗目标的评估时机,并强调肠道超声等影像学评估在监测治疗终点中的作用。

要点

  • IBD症状与肠道炎症活动度不一定相关,无症状不代表炎症已控制。
  • IBD管理目标已更新为临床缓解联合生化标志物和內镜下客观炎症指标。
  • 综述讨论各治疗目标的评估时机,并强调肠道超声在监测中的作用。

核心结论

  • IBD管理目标已更新为在临床终点基础上纳入客观炎症指标,包括生化标志物改善和內镜下指标,以客观测量和监测疾病缓解。

研究设计与样本

  • 综述,讨论评估IBD疾病活动度的不同策略及各治疗目标在门诊IBD诊疗中的评估时机,并强调影像学评估尤其是肠道超声监测治疗终点的作用。

主要发现

  • IBD症状存在与否并不总与活动性肠道炎症相关,无症状也不总代表炎症得到控制。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease, are disorders caused by inflammation in the gastrointestinal tract leading to a wide variety of symptoms. The presence of symptoms may not always correlate with active intestinal inflammation, and the lack of symptoms does not always indicate control of inflammation. Owing to the variable correlation between clinical symptoms and active intestinal inflammation, the targets for IBD management have been updated to include objective measures of inflammation to complement clinical end points. In addition to clinical remission, these targets include improvements in biochemical markers and endoscopic measures to objectively measure and monitor disease remission. In this review, we will discuss the different strategies for assessing disease activity and the timing of evaluation for each treatment target for outpatient IBD care. We will also highlight the role of radiographic assessment with a focus on intestinal ultrasound for monitoring these treatment end points.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Gaidos JKJ, Hashash JG. Monitoring Inflammatory Bowel Disease Activity: When, How, and Why. Am J Gastroenterol. 2025. PMID: 40488637. doi:10.14309/ajg.0000000000003582

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。